Press release
COPD Drug Market to Rise at an Estimated Value of USD 69.29 billion by 2026, Report by AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Chiesi Farmaceutici S.p.A and others
The Global Burden of Disease Study reports a prevalence of 251.00 million cases of chronic obstructive pulmonary disease (COPD) globally in 2016. Globally, it is estimated that 3.17 million deaths were caused by the disease in 2015 (that is, 5% of all deaths globally in that year)
Download Sample PDF Report https://databridgemarketresearch.com/request-a-sample/?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market
Global chronic obstructive pulmonary disease drug market is rising gradually to an estimated value of USD 69.29 billion by 2026 registering a steady CAGR of 4.3% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients, growing prevalence of chronic obstructive pulmonary disease (COPD) associated diseases and rising patient population and increase in availability of novel combination therapy drugs.
Key Market Players: Global COPD Drug Market
Few of the major competitors currently working in the chronic obstructive pulmonary disease (COPD) drug market are
• AstraZeneca
• Boehringer Ingelheim International GmbH
• GlaxoSmithKline plc
• Novartis AG
• Chiesi Farmaceutici S.p.A
• Sunovion Pharmaceuticals Inc
• Teva Pharmaceutical Industries Ltd
• Mylan N.V.
• Orion Corporation
• Merck & Co., Inc
• Abbott
• F. Hoffmann-La Roche Ltd
• Vectura Group plc
• Pfizer Inc
• Alkermes
• Mylan N.V
• Almirall
• S.A, Genentech, Inc
• Biogen
• Vectura Group plc and few among others
Key Developments in the Market:
• In April 2019, Circassia and AstraZeneca received collaborative FDA approval for Duaklir which is a fixed-dose combination of the long-acting muscarinic antagonist (LAMA) aclidinium bromide and long-acting beta-agonist (LABA) formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease (COPD), administered twice-daily via the AstraZeneca’s breath-actuated inhaler Pressair
• In February 2019, Mylan N.V received FDA approval for Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP) which is first generic version of Advair Diskus by GlaxoSmithKline Plc. This drug is used for the treatment of asthma or other chronic obstructive pulmonary disease (COPD). As it is a first substitutable generic of ADVAIR DISKUS it increases affordability to all healthcare system
Get Detailed TOC https://databridgemarketresearch.com/toc/?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market
Segmentation: Global Chronic Obstructive Pulmonary Disease (COPD) Drug Market
By Type
• Chronic bronchitis
• Pulmonary emphysema
• Asthma
By Mechanism Type
• Bronchodilators
• Selective β2-adrenergic agonists (short- and long-acting)
• Theophylline
• Anticholinergics
• Glucocorticoids
• Anti-muscarinic drugs
By Drug Type
• Aclidinium
• Arformoterol
• Formoterol
• Glycopyrrolate
• Indacaterol
• albuterol
• Levalbuterol
• Prednisolone
• Fluticasone
By Therapy
• Oxygen therapy
• Pulmonary Rehabilitation Program
By Route of Administration
• Oral
• Inhaled
• Intravenous
• Others
By Device Type
• Inhalers
• Pressurized metered-dose inhalers (MDIS)
• Dry-powder inhalers (DPIS)
• Nebulizers
• Soft mist inhalers
• Others
By End User
• Hospitals
• Homecare
• Specialty Clinics
• Others
By Geography
• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa
Global chronic obstructive pulmonary disease (COPD) drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of chronic obstructive pulmonary disease drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Speak to Author https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-chronic-obstructive-pulmonary-disease-copd-drug-market
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COPD Drug Market to Rise at an Estimated Value of USD 69.29 billion by 2026, Report by AstraZeneca, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Novartis AG, Chiesi Farmaceutici S.p.A and others here
News-ID: 1794172 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for COPD
Copd Drugs Market Size Analysis by Application, Type, and Region: Forecast to Co …
USA, New Jersey- According to Market Research Intellect, the global Copd Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
Because respiratory problems are becoming more common worldwide, especially among smokers and older populations, the market for COPD medications is expanding steadily. The need…
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market 2024-2030 Growth: …
Growth: Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Insights :
For stakeholders, an optimistic view is shown by the thorough study of the worldwide "Chronic Obstructive Pulmonary Disease (COPD) Treatment market". The research provides specifics on the market's historical and present conditions as well as projected trends and size. Decision-makers may navigate the competitive environment and investment possibilities in the Chronic Obstructive Pulmonary Disease (COPD) Treatment market with the use of…
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market - Breathing Sol …
Newark, New Castle, USA - new report, titled Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Obstructive Pulmonary Disease…
Asthma & COPD Drugs Market - Breathe Freely, Live Fully: Empowering Respiratory …
Newark, New Castle, USA - new report, titled Asthma & COPD Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Asthma & COPD Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Asthma & COPD Drugs market. The report offers…
Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing…
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's.
It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be…
